SELLAS Life Sciences (SLS) Depreciation & Amortization (CF) (2010 - 2017)
SELLAS Life Sciences' (SLS) quarterly Depreciation & Amortization (CF) came in at $25000.0 in Q3 2017, down 16.67% year-on-year from $30000.0 in Q3 2016, and little changed on a QoQ basis from $25000.0 in Q2 2017.
SELLAS Life Sciences (SLS) Depreciation & Amortization (CF) (2010 - 2017) Analysis & Trends
SELLAS Life Sciences (SLS) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $25000.0 in Q3 2017.
- On a quarterly basis, Depreciation & Amortization (CF) fell 16.67% year-over-year to $25000.0 in Q3 2017; TTM through Jun 2018 was $25000.0, a 327.27% increase from a year earlier, with the FY2016 full-year figure at $3000.0, down 97.2% from the prior year.
- Depreciation & Amortization (CF) for Q3 2017 stood at $25000.0, roughly flat from $25000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for SLS reached as high as $232000.0 in Q1 2014 and fell as low as -$254000.0 in Q4 2014.
- Historically, Depreciation & Amortization (CF) has averaged $29368.4 across 5 years, with a median of $30000.0 in 2016.
- On a YoY basis, Depreciation & Amortization (CF) climbed as much as 11500.0% in 2014 and fell as far as 315.25% in 2014.
- Year by year, Depreciation & Amortization (CF) stood at $118000.0 in 2013, then tumbled by 315.25% to -$254000.0 in 2014, then rose by 22.44% to -$197000.0 in 2015, then soared by 53.3% to -$92000.0 in 2016, then surged by 127.17% to $25000.0 in 2017.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $25000.0 in Q3 2017, $25000.0 in Q2 2017, and $26000.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 25,000.00 |
| Sep 30, 2017 | 25,000.00 |
| Jun 30, 2017 | 25,000.00 |
| Jun 30, 2017 | 25,000.00 |
| Mar 31, 2017 | 26,000.00 |
| Mar 31, 2017 | 26,000.00 |
| Dec 31, 2016 | -92,000.00 |
| Dec 31, 2016 | -92,000.00 |
| Sep 30, 2016 | 30,000.00 |
| Sep 30, 2016 | 30,000.00 |
| Jun 30, 2016 | 59,000.00 |
| Jun 30, 2016 | 59,000.00 |
| Mar 31, 2016 | 6,000.00 |
| Mar 31, 2016 | 6,000.00 |
| Dec 31, 2015 | -197,000.00 |
| Dec 31, 2015 | -197,000.00 |
| Sep 30, 2015 | 123,000.00 |
| Sep 30, 2015 | 123,000.00 |
| Jun 30, 2015 | 83,000.00 |
| Jun 30, 2015 | 83,000.00 |